287 related articles for article (PubMed ID: 22004671)
21. Urine specimen detection of concurrent nonprescribed medicinal and illicit drug use in patients prescribed buprenorphine.
Guo AY; Ma JD; Best BM; Atayee RS
J Anal Toxicol; 2013; 37(9):636-41. PubMed ID: 24080973
[TBL] [Abstract][Full Text] [Related]
22. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
[TBL] [Abstract][Full Text] [Related]
23. Urine drug testing of chronic pain patients. II. Prevalence patterns of prescription opiates and metabolites.
Heltsley R; Zichterman A; Black DL; Cawthon B; Robert T; Moser F; Caplan YH; Cone EJ
J Anal Toxicol; 2010; 34(1):32-8. PubMed ID: 20109300
[TBL] [Abstract][Full Text] [Related]
24. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the diagnostic performance of an oral fluid screening test device for substance abuse at traffic controls.
Avcioglu G; Yilmaz G; Yalcin Sahiner S; Kozaci LD; Bal C; Yilmaz FM
Clin Biochem; 2021 Jul; 93():112-118. PubMed ID: 33882283
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of heroin markers in urine for pain management patients.
Knight J; Puet BL; DePriest A; Heltsley R; Hild C; Black DL; Robert T; Caplan YH; Cone EJ
Forensic Sci Int; 2014 Oct; 243():79-83. PubMed ID: 24858136
[TBL] [Abstract][Full Text] [Related]
27. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid.
Allen KR; Azad R; Field HP; Blake DK
Ann Clin Biochem; 2005 Jul; 42(Pt 4):277-84. PubMed ID: 15989728
[TBL] [Abstract][Full Text] [Related]
28. Oral Fluid vs. Urine Analysis to Monitor Synthetic Cannabinoids and Classic Drugs Recent Exposure.
Blandino V; Wetzel J; Kim J; Haxhi P; Curtis R; Concheiro M
Curr Pharm Biotechnol; 2017; 18(10):796-805. PubMed ID: 29173162
[TBL] [Abstract][Full Text] [Related]
29. Screening for drugs in oral fluid: illicit drug use and drug driving in a sample of Queensland motorists.
Davey J; Leal N; Freeman J
Drug Alcohol Rev; 2007 May; 26(3):301-7. PubMed ID: 17454020
[TBL] [Abstract][Full Text] [Related]
30. Determination of 21 drugs in oral fluid using fully automated supported liquid extraction and UHPLC-MS/MS.
Valen A; Leere Øiestad ÅM; Strand DH; Skari R; Berg T
Drug Test Anal; 2017 May; 9(5):808-823. PubMed ID: 27464485
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of three rapid oral fluid test devices on the screening of multiple drugs of abuse including ketamine.
Tang MHY; Ching CK; Poon S; Chan SSS; Ng WY; Lam M; Wong CK; Pao R; Lau A; Mak TWL
Forensic Sci Int; 2018 May; 286():113-120. PubMed ID: 29574346
[TBL] [Abstract][Full Text] [Related]
32. Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugs.
Magura S; Lee-Easton MJ; Abu-Obaid R; Reed P; Allgaier B; Amaratunga P; Lorenz-Lemberg B; Levitas M; Achtyes ED
Drug Alcohol Depend; 2023 Sep; 250():110894. PubMed ID: 37481872
[TBL] [Abstract][Full Text] [Related]
33. An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.
Pesce A; Rosenthal M; West R; West C; Crews B; Mikel C; Almazan P; Latyshev S
Pain Physician; 2010; 13(3):273-81. PubMed ID: 20495592
[TBL] [Abstract][Full Text] [Related]
34. Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation.
Di Rago M; Chu M; Rodda LN; Jenkins E; Kotsos A; Gerostamoulos D
Anal Bioanal Chem; 2016 May; 408(14):3737-49. PubMed ID: 26993306
[TBL] [Abstract][Full Text] [Related]
35. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
Musshoff F; Hokamp EG; Bott U; Madea B
Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
[TBL] [Abstract][Full Text] [Related]
36. Analytical techniques for drug detection in oral fluid.
Lillsunde P
Ther Drug Monit; 2008 Apr; 30(2):181-7. PubMed ID: 18367978
[TBL] [Abstract][Full Text] [Related]
37. Opioids in oral fluid of Spanish drivers.
Herrera-Gómez F; García-Mingo M; Colás M; González-Luque JC; Álvarez FJ
Drug Alcohol Depend; 2018 Jun; 187():35-39. PubMed ID: 29626744
[TBL] [Abstract][Full Text] [Related]
38. Immunoassay in healthcare testing applications.
DePriest AZ; Black DL; Robert TA
J Opioid Manag; 2015; 11(1):13-25. PubMed ID: 25750161
[TBL] [Abstract][Full Text] [Related]
39. Illicit drug use in the pain patient population decreases with continued drug testing.
Pesce A; West C; Rosenthal M; Mikel C; West R; Crews B; Almazan P; Latyshev S; Horn PS
Pain Physician; 2011; 14(2):189-93. PubMed ID: 21412373
[TBL] [Abstract][Full Text] [Related]
40. Urine drug testing results and paired oral fluid comparison from patients enrolled in long-term medication-assisted treatment in Tennessee.
Miller KL; Puet BL; Roberts A; Hild C; Carter J; Black DL
J Subst Abuse Treat; 2017 May; 76():36-42. PubMed ID: 28131519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
